SUMMARY Seven volunteers aged 12-0 to 17*9 years participated in a trial to compare conventional insulin treatment with continuous open loop (pump) insulin infusion. After 6 weeks of conventional treatment followed by 6 weeks of insulin pump treatment, 4 children chose to manage their diabetes permanently by means of the insulin pump. The mean blood glucose concentration (based on home blood glucose monitoring) while on conventional insulin treatment showed no appreciable change during the 6 weeks' treatment on an insulin pump. Compared with conventional treatment, however, the mean 24 hour blood glucose profiles of the patients on pump insulin showed less variation in the blood glucose throughout the day, together with an appreciably lower peak after breakfast. These improvements occurred despite increased dietary flexibility while on pump insulin. The insulin pump seems to be an acceptable form of treatment for some children and young adults with diabetes mellitus and gives near physiological control of blood glucose.
Insulin pumps have been used successfully in the management of diabetes mellitus in the past few years.' There have been published reports of their use in younger adults2 but their main clinical application has been in the management of the older patient (mostly in research trials)3 and in patients who have clinically unstable diabetes.4 The introduction of pumps has been widespread in the United States where it is estimated that between 4000 and 5000 diabetic patients use them.5 In the United Kingdom, however, their use has been more limited.
We investigated the use of insulin pumps in children and young adults, noting their acceptability and influence on blood glucose control. We report the results of this study, carried out in the Oxford Paediatric Diabetic Clinic over the past 12 months.
Patients and methods
We were interested primarily in insulin pumps in the management of the 'average child' with diabetes.
We did not choose preferentially patients with 'brittle diabetes', although some of our patients had had periods of appreciable clinical instability. Twenty three likely candidates (8 girls, 15 boys) attending the paediatric clinic were approached as potential insulin pump users. All were aged 10 years and over, and during discussions in the clinic had expressed an interest in the pump. In the event only 7 patients volunteered for the trial; all were boys aged 12 to 17.9 years (mean 14.6 years) and the duration of their diabetes ranged from 3.5 to 7-1 years (mean 5.7 years) (Table) . They came from various socioeconomic backgrounds-social class 1(2), II(1), 111(4) (Office of Population Censuses and Surveys). Three patients were receiving twice daily The 7 patients were on conventional insulin for 6 weeks followed by insulin pump for a minimum of 6 weeks. The mean of all home blood glucose measurements and glycosylated haemoglobin values obtained on conventional and pump treatment are shown in Fig. 1 . The blood glucose concentration of the 7 patients on conventional insulin treatment (mean (SD) 9-0 (1.4) mmol/l (162.16 (25-23) mg/100 ml)) showed improvement during the 6 weeks on pump treatment (mean (SD) 8*1 On conventional treatment there were the expected peaks and troughs in the 24 hour blood glucose profiles.8 In all 7 children on pump treatment the peaks and troughs were reduced and the SD of the blood glucose value fell at each of the 7 selected points in the day. There was a significant difference between conventional treatment and pump treatment in the post-breakfast blood glucose peak-conventional, mean (SD) 13.4 (3.9) mmol/l (241.44 (70X27) mg/100 ml); pump, mean (SD) 7.9 (1.9) mmol/I (142.34 (34.23) mg/100 ml); P< 0-01, Student's t test (Fig. 2) . The 24 hour insulin dose did not change appreciably between conventional and pump treatment.
All children made substantial alterations to their diet on changing to pump insulin with the omission of morning and afternoon snacks and variation in the timing of the carbohydrate content of the main meals but there was no appreciable change in weight on either treatment. All children said they felt better and healthier while on the pump and this was confirmed by their parents. One patient developed a small area of cellulitus at the infusion site which resolved on resiting the needle, but there were no serious episodes of hypoglycaemia or diabetic ketosis on either treatment. One child aged 12 years was admitted to hospital 2 weeks after starting pump treatment because of erratic blood glucose control, but this improved with further instructions on using the pump.
Discussion
This study confirms to some degree the published reports that improved control in adults can be achieved by insulin pump treatment1 2 and that pumps are acceptable to children and young adults. Although patients were not randomly divided into 2 groups according to which form of treatment came first, equal effort was made to optimise blood glucose control in each period. Two of the children who had clinically unstable diabetes before entering the trial achieved more stable metabolic control together with an overall improvement in their general health. Insulin pump treatment produced a 'flatter' 24 hour blood glucose profile with a reduction in the post-breakfast peak (Fig. 2) .
The main clinical benefit of the insulin pump reported by the children was flexibility in the daily routine, particularly diet. Meals were omitted or delayed and as confidence in the use of pumps grew, preprandial insulin dosagewas adjusted depending on the carbohydrate content of the meal. With similar changes in dietary routine on conventional treatment, blood glucose control would be expected to deteriorate.
The basal infusion rate was adjusted according to the pre-breakfast blood glucose concentration. Limited data of blood glucose values at 3 am suggested that this was satisfactory as nocturnal hypoglycaemia was avoided. The 3 am and prebreakfast blood glucose values were in the upper range of normal-6.1 mmol/l (109.91 mg/100 ml) and 8*1 mmol/l (145.95 mg/100ml) respectively. These concentrations, similar to those recommended by Unger5 in his cautionary note on possible dangers associated with meticulous control of diabetes by insulin infusion pump, were suggested to avoid severe nocturnal hypoglycaemia, a factor implicated in a report from the United States8 9 on 12 deaths in diabetic adults using insulin infusion pumps.
The complications with insulin pumps were minimal. One patient had mild cellulitis that was treated by removal of the needle; 1 child required a second hospital admission to improve his understanding of the pump system. All of the children passed through a phase of disenchantment with the pump in the first 2 weeks, but by the end of the 6 weeks were at ease with the management of their diabetes in this way. Four patients, aged 12, 15, 16, and 17 years, chose to continue with their pumps.
Several imperfections in the systems were noted by all the children. Particularly noteworthy was the overall size of the pump, with bulk rather than weight causing problems. This was overcome to some extent in 2 children who used the Graseby Dynamic pump by wearing the system in a shoulder holster. There were no mechanical errors or pump failures but on 2 occasions there was breakage of the insulin syringe at the point of connection with the infusion systems. On 5 occasions the needle became dislodged at the infusion site in the abdominal wall; mild hyperglycaemia, detected by the children themselves, resulted. There were no difficulties with attachment of the machine by day or night and sleeping was not a problem. Attendance at school was unaffected as were all other everyday activities.
Several objections have been raised to the widespread clinical use of insulin pumps. Cost is obviously an important consideration: the machines are expensive to buy, and their running costs are high compared with conventional treatment. Despite this, the parents of 4 diabetic children expressed a desire to purchase their own systems.
Another important consideration is the burden placed on clinic staff by the extra care and advice required to convert large numbers of patients safely to insulin infusion pumps. The patients require a clear understanding and must be prepared to monitor their diabetes closely by measuring blood glucose at home.
Despite these reservations this study has shown that insulin pump systems are an acceptable treatment for young adults and children with insulin dependent diabetes mellitus. They offer near physiological control of blood glucose while releasing the child from some of the rigidity of the daily routine. It is envisaged that developments in pump technology will result in new generations of less expensive and more compact machines. 
